DUSP5P1 and gastric cancer: After stratification by tumor staging, high DUSP5P1 predicted poor prognosis in stage I-II GC patients both in Cohort I (P = 0.0201) (Fig. 1D) and in Cohort II (OS, P = 0.0203; PFS, P = 0.0482) (Fig. 1E).